Cochlear Ltd

COH: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
A$268.00HbjhMjgsjqqcg

Coronavirus Dip Not As Deep as Expected, but Near-Term Outlook Still Uncertain for Cochlear

Business Strategy and Outlook

Cochlear is the market leader in cochlear implants with consistent market share of roughly 60%. Cochlear implants became the standard of care many years ago for children in developed markets with profound hearing loss or deafness. With this market largely penetrated, the company is looking elsewhere for growth with developed market adults the next primary focus, and emerging market children after that.

Sponsor Center